Related Experiment Videos
Chemoradiation-induced cell loss in human submandibular glands
Christopher A Sullivan1, Robert I Haddad, Roy B Tishler
1Department of Otolaryngology--Head and Neck Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157, USA. csulliva@wfubmc.edu
The Laryngoscope
|June 4, 2005
Summary
Chemoradiation damages submandibular glands in head and neck cancer patients, causing xerostomia. Acinar cell loss and fibrosis are key findings, while the ductal system remains preserved.
Area of Science:
- Oncology
- Pathology
- Salivary Gland Biology
Background:
- Chemoradiation therapy frequently causes xerostomia, impacting quality of life for head and neck cancer patients.
- Limited human histopathologic data exists on non-acute salivary gland damage post-chemoradiation.
Purpose of the Study:
- To characterize the histopathologic and immunohistochemical features of human submandibular glands in the non-acute phase after chemoradiation therapy.
- To provide insights into the mechanisms of xerostomia development.
Main Methods:
- Histologic and immunohistochemical analyses of submandibular glands from patients treated with chemoradiotherapy for head and neck cancer.
- Comparison of chemoradiated glands with age- and sex-matched untreated control glands.
Main Results:
- Significant acinar cell loss, ductal metaplasia, fibrosis, chronic inflammation, and nuclear atypia were observed in chemoradiated glands.
- Ductal epithelium and microvascular density showed relative preservation.
- Findings suggest primary dysfunction stems from acinar cell damage.
Conclusions:
- Non-acute chemoradiation injury to human submandibular glands involves significant acinar cell loss and fibrosis.
- The ductal system appears resilient to chemoradiation.
- Understanding these changes is crucial for managing xerostomia in head and neck cancer survivors.